Insider Transactions in Q1 2025 at Fennec Pharmaceuticals Inc. (FENC)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 28
2025
|
Rosty Raykov |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+3.0%
|
-
|
|
Feb 28
2025
|
Robert Andrade CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
1,042
+0.79%
|
-
|
|
Feb 14
2025
|
Chris A Rallis |
SELL
Open market or private sale
|
Direct |
1,186
-2.19%
|
$7,116
$6.82 P/Share
|
|
Feb 14
2025
|
Chris A Rallis |
BUY
Exercise of conversion of derivative security
|
Direct |
1,992
+3.54%
|
$3,984
$2.51 P/Share
|
|
Feb 05
2025
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
10,000
-11.59%
|
$60,000
$6.66 P/Share
|
|
Jan 31
2025
|
Rosty Raykov |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+2.74%
|
-
|
|
Jan 31
2025
|
Robert Andrade CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
1,042
+0.79%
|
-
|
|
Jan 06
2025
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
10,000
-5.43%
|
$60,000
$6.08 P/Share
|